Michael Sofia
2016
In 2016, Michael Sofia earned a total compensation of $754.3K as Chief Scientific Officer at Arbutus Biopharma Corp, a 75% increase compared to previous year.
Compensation breakdown
| Bonus | $105,000 |
|---|---|
| Option Awards | $290,264 |
| Salary | $350,000 |
| Other | $9,000 |
| Total | $754,264 |
Sofia received $350K in salary, accounting for 46% of the total pay in 2016.
Sofia also received $105K in bonus, $290.3K in option awards and $9K in other compensation.
Rankings
In 2016, Michael Sofia's compensation ranked 9,542nd out of 14,075 executives tracked by ExecPay. In other words, Sofia earned more than 32.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,542 out of 14,075 | 32nd |
Division Manufacturing | 3,695 out of 5,489 | 33rd |
Major group Chemicals And Allied Products | 1,284 out of 1,895 | 32nd |
Industry group Drugs | 1,020 out of 1,538 | 34th |
Industry Pharmaceutical Preparations | 803 out of 1,176 | 32nd |
Source: SEC filing on April 18, 2017.
Sofia's colleagues
We found six more compensation records of executives who worked with Michael Sofia at Arbutus Biopharma Corp in 2016.
2016
Mark Murray
Arbutus Biopharma Corp
Chief Executive Officer
2016
Mark Kowalski
Arbutus Biopharma Corp
Chief Medical Officer
2016
Patrick Higgins
Arbutus Biopharma Corp
Former Chief Business and Commercial Operations Officer
2016
Bruce Cousins
Arbutus Biopharma Corp
Chief Financial Officer
2016
Elizabeth Howard
Arbutus Biopharma Corp
General Counsel
2016
Peter Lutwyche
Arbutus Biopharma Corp
Chief Technology Officer
News
Arbutus Biopharma Corp CEO William Collier's 2023 pay jumps 28% to $3.4M
April 10, 2024
Arbutus Biopharma Corp CEO William Collier's 2022 pay slips 18% to $2.6M
April 12, 2023
Arbutus Biopharma Corp CEO William Collier's 2021 pay rises 18% to $3.2M
April 11, 2022
Arbutus Biopharma Corp CEO William Collier's 2020 pay rises 17% to $2.7M
April 8, 2021
Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
April 24, 2020